Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients
Francesca L. Sciacca(Rega Institute for Medical Research), Luigi M.E. Grimaldi, Maria Giovanna Marrosu(University of Cagliari), Gianvito Martino(Vita-Salute San Raffaele University), Giacomo P. Comi(University of Milan), Claudio Gobbi(Laboratory for Biomedical Neurosciences), Cinzia Ferri, Koen Vandenbroeck(Ikerbasque), Fabrizio Veglia, D. Franciotta(Rega Institute for Medical Research), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), N. Canal(University of Milan), Vittorio Martinelli(Vita-Salute San Raffaele University)
Cited by 85
Related Papers
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Multiple Sclerosis Severity Score
|Neurology|2005|959
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
|Neuron|2018|724